Usher綜合征伴黃斑水腫1例_Chinese Journal of Ocular Fundus Diseases

Authors：

張敏 ¹ , 董照陽 ¹ , 周昀 ² ,  魏偉 ³

1. ;
2. ;
3. ;

Corresponding?author：

魏偉, Email: 13951776603@163.com

Keywords：

Usher綜合征; 視網膜色素變性; 黃斑水腫; 碳酸酐酶抑制劑; 病例報告

DOI：

10.3760/cma.j.cn511434-20221103-00577

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 張敏, 董照陽, 周昀, 魏偉. Usher綜合征伴黃斑水腫1例. Chinese Journal of Ocular Fundus Diseases, 2024, 40(3): 230-232. doi: 10.3760/cma.j.cn511434-20221103-00577 Copy

1.	Bakthavatchalam M, Lai FHP, Rong SS, et al. Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review[J]. Surv Ophthalmol, 2018, 63(3): 329-339. DOI: 10.1016/j.survophthal.2017.09.009.
2.	Chen C, Liu X, Peng X. Management of cystoid macular edema in retinitis pigmentosa: a systematic review and meta-analysis[J/OL]. Front Med (Lausanne), 2022, 9: 895208[2022-05-16]. https://pubmed.ncbi.nlm.nih.gov/35652079/. DOI: 10.3389/fmed.2022.895208.
3.	Strong S, Liew G, Michaelides M. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention[J]. Br J Ophthalmol, 2017, 101(1): 31-37. DOI: 10.1136/bjophthalmol-2016-309376.
4.	Park UC, Park JH, Yoon CK, et al. Microstructral changes in cystoid macular edema in retinitis pigmentosa after intravitreal dexamethasone implant injection[J]. Retina, 2021, 41(4): 852-860. DOI: 10.1097/IAE.0000000000002944.
5.	Karasu B. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors[J]. Int Ophthalmol, 2020, 40(3): 677-687. DOI: 10.1007/s10792-019-01228-z.
6.	Mansour AM, Sheheitli H, Kucukerdonmez C, et al. Intravitreal dexamethasone implant in retinitis pigmentosa-related cystoid mcular edema[J]. Retina, 2018, 38(2): 416-423. DOI: 10.1097/IAE.0000000000001542.
7.	Veritti D, Sarao V, De Nadai K, et al. Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa[J]. J Ocul Pharmacol Ther, 2020, 36(3): 190-197. DOI: 10.1089/jop.2018.0153.
8.	Park UC, Park JH, Ma DJ, et al. A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa[J]. Retina, 2020, 40(7): 1359-1366. DOI: 10.1097/IAE.0000000000002589.
9.	Strong SA, Peto T, Bunce C, et al. Prospective exploratory study to assess the safety and efficacy of Aflibercept in cystoid macular oedema associated with retinitis pigmentosa[J]. Br J Ophthalmol, 2020, 104(9): 1203-1208. DOI: 10.1136/bjophthalmol-2019-315152.
10.	Arslan U. Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser[J]. Lasers Med Sci, 2021, 36(2): 317-323. DOI: 10.1007/s10103-020-03031-0.
11.	García-Arumí J, Martinez V, Sararols L, et al. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa[J]. Ophthalmology, 2003, 110(6): 1164-1169. DOI: 10.1016/S0161-6420(03)00259-8.
12.	Kim YJ, Joe SG, Lee DH, et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa[J]. Invest Ophthalmol Vis Sci, 2013, 54(2): 1303-1309. DOI: 10.1167/iovs.12-10149.
13.	Koyanagi Y, Murakami Y, Funatsu J, et al. Optical coherence tomography angiography of the macular microvasculature changes in retinitis pigmentosa[J/OL]. Acta Ophthalmol, 2018, 96(1): e59-e67[2017-05-31]. https://pubmed.ncbi.nlm.nih.gov/28561452/. DOI: 10.1111/aos.13475.
14.	Walia S, Fishman GA, Hajali M. Prevalence of cystic macular lesions in patients with Usher II syndrome[J]. Eye (Lond), 2009, 23(5): 1206-1209. DOI: 10.1038/eye.2008.105.

1. Bakthavatchalam M, Lai FHP, Rong SS, et al. Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review[J]. Surv Ophthalmol, 2018, 63(3): 329-339. DOI: 10.1016/j.survophthal.2017.09.009.
2. Chen C, Liu X, Peng X. Management of cystoid macular edema in retinitis pigmentosa: a systematic review and meta-analysis[J/OL]. Front Med (Lausanne), 2022, 9: 895208[2022-05-16]. https://pubmed.ncbi.nlm.nih.gov/35652079/. DOI: 10.3389/fmed.2022.895208.
3. Strong S, Liew G, Michaelides M. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention[J]. Br J Ophthalmol, 2017, 101(1): 31-37. DOI: 10.1136/bjophthalmol-2016-309376.
4. Park UC, Park JH, Yoon CK, et al. Microstructral changes in cystoid macular edema in retinitis pigmentosa after intravitreal dexamethasone implant injection[J]. Retina, 2021, 41(4): 852-860. DOI: 10.1097/IAE.0000000000002944.
5. Karasu B. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors[J]. Int Ophthalmol, 2020, 40(3): 677-687. DOI: 10.1007/s10792-019-01228-z.
6. Mansour AM, Sheheitli H, Kucukerdonmez C, et al. Intravitreal dexamethasone implant in retinitis pigmentosa-related cystoid mcular edema[J]. Retina, 2018, 38(2): 416-423. DOI: 10.1097/IAE.0000000000001542.
7. Veritti D, Sarao V, De Nadai K, et al. Dexamethasone implant produces better outcomes than oral acetazolamide in patients with cystoid macular edema secondary to retinitis pigmentosa[J]. J Ocul Pharmacol Ther, 2020, 36(3): 190-197. DOI: 10.1089/jop.2018.0153.
8. Park UC, Park JH, Ma DJ, et al. A randomized paired-eye trial of intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa[J]. Retina, 2020, 40(7): 1359-1366. DOI: 10.1097/IAE.0000000000002589.
9. Strong SA, Peto T, Bunce C, et al. Prospective exploratory study to assess the safety and efficacy of Aflibercept in cystoid macular oedema associated with retinitis pigmentosa[J]. Br J Ophthalmol, 2020, 104(9): 1203-1208. DOI: 10.1136/bjophthalmol-2019-315152.
10. Arslan U. Management of cystoid macular edema secondary to retinitis pigmentosa via subliminal micropulse yellow laser[J]. Lasers Med Sci, 2021, 36(2): 317-323. DOI: 10.1007/s10103-020-03031-0.
11. García-Arumí J, Martinez V, Sararols L, et al. Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa[J]. Ophthalmology, 2003, 110(6): 1164-1169. DOI: 10.1016/S0161-6420(03)00259-8.
12. Kim YJ, Joe SG, Lee DH, et al. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa[J]. Invest Ophthalmol Vis Sci, 2013, 54(2): 1303-1309. DOI: 10.1167/iovs.12-10149.
13. Koyanagi Y, Murakami Y, Funatsu J, et al. Optical coherence tomography angiography of the macular microvasculature changes in retinitis pigmentosa[J/OL]. Acta Ophthalmol, 2018, 96(1): e59-e67[2017-05-31]. https://pubmed.ncbi.nlm.nih.gov/28561452/. DOI: 10.1111/aos.13475.
14. Walia S, Fishman GA, Hajali M. Prevalence of cystic macular lesions in patients with Usher II syndrome[J]. Eye (Lond), 2009, 23(5): 1206-1209. DOI: 10.1038/eye.2008.105.

Chinese Journal of Ocular Fundus Diseases

Usher綜合征伴黃斑水腫1例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content